Targeting protein kinase CK2 and CDK4/6 pathways with a multi-kinase inhibitor ON108110 suppresses pro-survival signaling and growth in mantle cell lymphoma and T-acute lymphoblastic leukemia

使用多激酶抑制剂 ON108110 靶向蛋白激酶 CK2 和 CDK4/6 通路可抑制套细胞淋巴瘤和 T 细胞急性淋巴细胞白血病中的促生存信号传导和细胞生长。